Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT02712203
Eligibility Criteria:
Inclusion Criteria:
* Healthy male or female subject between 11 to 22 months at the time of first vaccination.
* Written informed consent obtained from the parent/guardian of the subject.
Exclusion Criteria:
* History of previous measles, mumps, rubella and/or varicella vaccination or disease or known exposure to any of these diseases within 30 days prior to the inclusion in the study.
* Any confirmed or suspected immunosuppressive or immunodeficient condition, included the chronic administration (defined as more than 14 days) of immune-suppressants or other immune-modifying drugs within six months prior to the firs vaccine dose.
* History of any neurologic disorders or seizures.
* History of allergic diseases or reactions likely to be exacerbated by any component of the vaccines.
* Planned administration of a vaccine not foreseen by the study protocol from 30 days prior to each vaccination until 42-56 days after each vaccination
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
11 Months
Maximum Age:
22 Months
Study:
NCT02712203
Study Brief:
Protocol Section:
NCT02712203